Exploring untapped potentials at the Asia-Pacific digital pathology market
Medical Diagnostic | Opinion | By Hithaishi C Bhaksar | 0 Comment | 14 Jun, 2022
The synergy of AI and digital pathology has opened a world of image-based possibilities that can transform disease diagn...Read more
Health tech firm Annalise partners with Fujifilm Australia
Medical Diagnostic | News | 0 Comment | 08 Jun, 2022
Sydney based Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision s...Read more
Singapore's Us2.ai expands multi-modality echocardiography AI analytics reach
Medical Diagnostic | News | 0 Comment | 08 Jun, 2022
Us2.ai, a Singapore-based medtech firm has received CE Mark clearance for Us2.v1, a completely automated decision suppor...Read more
Parse Biosciences inks pact with Molecular Diagnostics Korea
Medical Diagnostic | News | 0 Comment | 07 Jun, 2022
US-based Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, has announced a partnership...Read more
MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility
Medical Diagnostic | News | 0 Comment | 30 May, 2022
MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, and A*STAR spinoff, focused on s...Read more
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
Medical Diagnostic | News | 0 Comment | 26 May, 2022
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has unveiled a global initiative for ...Read more
New Horizon Health partners with Prenetics to launch non-invasive colon cancer test
Medical Diagnostic | News | 0 Comment | 24 May, 2022
New Horizon Health and Prenetics has announced a strategic partnership to launch ColoClear by Circle, the "First Colorec...Read more
INEX Innovate set to launch ovarian cancer detection test in Southeast Asian markets
Medical Diagnostic | News | 0 Comment | 11 May, 2022
Known as a pioneer in Asia's women's and foetal health industry, Singapore-based diagnostics developer, I...Read more
Japan-based Hitachi advances molecular diagnostics and precision medicine
Medical Diagnostic | News | 0 Comment | 10 May, 2022
Hitachi High-Tech Corporation, headquartered in Tokyo, Japan, has entered into a strategic partnership with In...Read more
KYAN Therapeutics, Curie Oncology offer personalised cancer test in Singapore
Medical Diagnostic | News | 0 Comment | 10 May, 2022
KYAN Therapeutics (a Delaware Corporation headquartered in Singapore) teams up with Curie Oncology to offer its novel an...Read more
Taiwan's iXensor receives strategic investment to expand mobile health biz globally
Medical Diagnostic | News | 0 Comment | 28 Apr, 2022
Taiwan's iXensor, the pioneer of mobile health, has announced that Rohto Pharmaceutical Co., Ltd, a multinational pharma...Read more
Zymo Research invests in Singapore's Star Array to develop superfast PCR platform
Medical Diagnostic | News | 0 Comment | 28 Apr, 2022
US-based Zymo Research is making a strategic investment to acquire an interest in Star Array, a privately owned, biomedi...Read more
Korea's Seegene unveils world's first commercialised '3 Ct' PCR assay
Medical Diagnostic | News | 0 Comment | 27 Apr, 2022
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has announced the development of the ...Read more
Volition launches Nu.Q Vet Cancer test in Asia
Medical Diagnostic | News | 0 Comment | 26 Apr, 2022
VolitionRx, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diag...Read more
Korea develops COVID-19 detection platform by 'slowing down light'
Medical Diagnostic | News | 0 Comment | 22 Apr, 2022
A research group led by Professor Young Min Song of the Gwangju Institute of Science and Technology in Korea h...Read more
Japan's Kaneka releases new PCR detection kits for Omicron and Occult Omicron variants
Medical Diagnostic | News | 0 Comment | 18 Apr, 2022
Japan-based Kaneka Corporation has released a product that can simultaneously detect COVID-19 - Real-time PCR detection ...Read more
Australia's Telix starts US trial
Medical Diagnostic | News | 0 Comment | 18 Apr, 2022
Australia's Telix Pharmaceuticals has announced first commercial doses of its prostate cancer imaging agent, Illuccix&re...Read more
US authorises first COVID-19 diagnostic test using breath samples
Medical Diagnostic | News | 0 Comment | 15 Apr, 2022
U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnosti...Read more